Clinical Trial Update: Montelukast in Bronchiolitis Obliterans Syndrome [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating montelukast in bronchiolitis obliterans syndrome after lung transplantation has completed. The study also assessed graft rej…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiolitis Obliterans Syndrome
• Transplant Rejection

Drugs mentioned

• Montelukast (Montelukast)
• SINGULAIR (montelukast)

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Bronchiolitis Obliterans, Lung Transplantation | Phase 4 | Status: COMPLETED